3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
12
Neoplasms
7
Fatigue
6
Prostatic Neoplasms
5
Lung Neoplasms
5
Motor Activity
4
Lymphedema
4
Hematologic Neoplasms
4
Pain
3
Trismus
2
Peripheral Nervous System Diseases
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Glioma
2
Esophageal Neoplasms
2
Cachexia
2
Breast Neoplasms, Male
2
Urologic Neoplasms
1
Urinary Incontinence
1
Urinary Bladder Neoplasms
1
Transcranial Magnetic Stimulation, Repetitive
1
Thrombosis
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sleep Initiation and Maintenance Disorders
1
Shoulder Pain
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Interventions
Cisplatin
6
pembrolizumab
5
fludarabine
5
Nivolumab
5
Cyclophosphamide
5
aldesleukin
4
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Ifosfamide
4
Radiotherapy
3
Ipilimumab
3
fludarabine phosphate
2
entinostat
2
cabozantinib
2
avelumab
2
aflibercept
2
Specimen Handling
2
CTLA-4 Antigen
2
Adoptive Transfer
2
vinflunine
1
toripalimab
1
rocakinogene sifuplasmid
1
ripretinib
1
oncogene protein E7, Human papillomavirus type 16
1
niraparib
1
nimotuzumab
1
lenvatinib
1
enfortumab vedotin
1
durvalumab
1
dostarlimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Penile Neoplasms
×
Physical Therapy Modalities
×
Clear all
NCT05946993
2026-05-01
LIAM Mc
University College Cork
Phase NA
Active not recruiting
72 enrolled